On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Green Hygienics Holdings Inc. (GRYN) Announces Partnership with Leading Hemp Law Firm

  • GRYN positioning itself for rapid growth in 2021
  • Retaining expert counsel with innate understanding of cannabis law is necessary step as company builds highly differentiated business model
  • Green Hygienics’ growth strategy includes rollout of omnichannel bricks-and-clicks program featuring multiple premium brands
As Green Hygienics Holdings (OTCQB: GRYN) wraps up its first successful crop harvest and enters the wholesale retail stage of development, the company has engaged the services of McAllister Garfield, PC, a top law firm in the industrial hemp space. GRYN, an innovative technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, made the decision in anticipation of rapid growth in 2021. “When lawmakers tighten the belt on hemp regulations, Green Hygienics is positioning itself to be ahead of the curve and thrive,” said Green Hygienics CEO Ron Loudoun. “Navigating regulatory compliance in an emerging industry is no small task, but a very important one to our company, and retaining counsel of such an established law firm with an innate understanding of cannabis law is a necessary step as we build out our highly differentiated business model.” In addition to retaining McAllister Garfield, part of Green Hygienics’ strategy for growth includes the rollout of an omnichannel bricks-and-clicks program featuring multiple premium brands layering over different market segments in the hemp industry. GRYN’s partnership with McAllister Garfield will provide insight and expertise in navigating regulatory compliance issues. The firm will also provide invaluable advice and support throughout the rollout, including assistance with retail opportunities. Specifically, GRYN is working with McAllister Garfield to obtain three business licenses in the downtown vicinity of San Diego for the following:
  • a hemp-centric coffee house
  • a smoking lounge
  • An all-things-hemp dispensary and storefront
“We are pleased to be working with Green Hygienics Holdings, Inc., a promising company which puts a focus on compliance and consumer safety,” said McAllister Garfield’s hemp/CBD chairman David Wunderlich. “McAllister Garfield provides sophisticated business advice lending guidance on foundational documents, mergers and acquisitions, transactional and employment law, litigation, and administrative regulatory enforcement. Our team of lawyers has been present in the hemp industry from the very beginnings and offers a suite of solutions helping our clients through to positive outcomes as they run the regulatory gauntlet.” Green Hygienics is committed to consistently delivering safe, premium-quality products to consumers; the company is also looking to partner with CPG (consumer-packaged-goods) and pharmaceutical companies in its mission to offer hemp-based products that consumers are searching for. GRYN is focused on becoming a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. In addition, GRYN is exploring the full range of novel cannabinoids and targeted bio-delivery technologies with the objective of solving issues of stability, pharmacokinetics, biological tissue penetration and bioavailability. The company has assembled a team of visionary agrotechnology, pharmaceutical, and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with the mission to improve lives. For more information, visit the company’s website at www.GreenHygienics.com. NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

From Our Blog

“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”

April 24, 2024

In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation unfolding in Malawi, East Africa. The Ministry of Health (“MOH”) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping […]

Rotate your device 90° to view site.